company background image
IBP logo

Indo-Bangla Pharmaceuticals DSE:IBP Stock Report

Last Price

৳10.00

Market Cap

৳1.2b

7D

5.3%

1Y

-47.6%

Updated

07 Feb, 2025

Data

Company Financials

Indo-Bangla Pharmaceuticals Limited

DSE:IBP Stock Report

Market Cap: ৳1.2b

IBP Stock Overview

Engages in the manufacture and sale of various medicines, medical preparations drugs, and chemicals in Bangladesh and internationally. More details

IBP fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Indo-Bangla Pharmaceuticals Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Indo-Bangla Pharmaceuticals
Historical stock prices
Current Share Price৳10.00
52 Week High৳20.80
52 Week Low৳6.80
Beta0.18
1 Month Change0%
3 Month Change14.94%
1 Year Change-47.64%
3 Year Change-45.79%
5 Year Change-57.81%
Change since IPO-71.57%

Recent News & Updates

Recent updates

Shareholder Returns

IBPBD PharmaceuticalsBD Market
7D5.3%-0.05%1.0%
1Y-47.6%-30.2%-19.4%

Return vs Industry: IBP underperformed the BD Pharmaceuticals industry which returned -30.2% over the past year.

Return vs Market: IBP underperformed the BD Market which returned -19.4% over the past year.

Price Volatility

Is IBP's price volatile compared to industry and market?
IBP volatility
IBP Average Weekly Movement5.5%
Pharmaceuticals Industry Average Movement5.2%
Market Average Movement4.8%
10% most volatile stocks in BD Market6.9%
10% least volatile stocks in BD Market2.5%

Stable Share Price: IBP has not had significant price volatility in the past 3 months compared to the BD market.

Volatility Over Time: IBP's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1954152A. F. M. Huqwww.indo-banglapharma.com

Indo-Bangla Pharmaceuticals Limited engages in the manufacture and sale of various medicines, medical preparations drugs, and chemicals in Bangladesh and internationally. Its principal products include analgesics and antipyretics, anthelmintic, anti-asthmatic, gastroprokinetic and antiemetic, antiprotozoal, non-hormone sex stimulant, non-steroidal, anti-inflammatory, steroids, and vitamins and minerals, as well as respiratory, cardiovascular, central nervous system, dermatology, and gastrointestinal categories. The company markets its products in various forms, such as tablets, capsules, intravenous fluids, liquids, suppositories, and injectables.

Indo-Bangla Pharmaceuticals Limited Fundamentals Summary

How do Indo-Bangla Pharmaceuticals's earnings and revenue compare to its market cap?
IBP fundamental statistics
Market cap৳1.16b
Earnings (TTM)-৳44.98m
Revenue (TTM)৳119.08m

9.8x

P/S Ratio

-25.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IBP income statement (TTM)
Revenue৳119.08m
Cost of Revenue৳109.27m
Gross Profit৳9.81m
Other Expenses৳54.79m
Earnings-৳44.98m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.39
Gross Margin8.23%
Net Profit Margin-37.78%
Debt/Equity Ratio1.7%

How did IBP perform over the long term?

See historical performance and comparison

Dividends

0.1%

Current Dividend Yield

-3%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/07 01:27
End of Day Share Price 2025/02/06 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Indo-Bangla Pharmaceuticals Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.